Fidelity Investments’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$891K Buy
375,815
+109,808
+41% +$380K ﹤0.01% 2912
2025
Q4
$1.38M Buy
266,007
+24,828
+10% +$120K ﹤0.01% 2736
2025
Q3
$1.02M Buy
241,179
+47,676
+25% +$222K ﹤0.01% 2793
2025
Q2
$708K Sell
193,503
-44,160
-19% -$165K ﹤0.01% 2841
2025
Q1
$1.03M Sell
237,663
-5,815
-2% -$23.5K ﹤0.01% 2667
2024
Q4
$779K Buy
243,478
+69,883
+40% +$234K ﹤0.01% 2764
2024
Q3
$496K Buy
173,595
+44,199
+34% +$124K ﹤0.01% 2859
2024
Q2
$362K Buy
129,396
+44,744
+53% +$120K ﹤0.01% 2841
2024
Q1
$240K Sell
84,652
-497
-0.6% -$1.69K ﹤0.01% 2973
2023
Q4
$348K Sell
85,149
-1,149
-1% -$3.22K ﹤0.01% 2784
2023
Q3
$274K Sell
86,298
-299
-0.3% -$950 ﹤0.01% 2782
2023
Q2
$288K Buy
86,597
+83,527
+2,721% +$247K ﹤0.01% 2836
2023
Q1
$6.54K Buy
3,070
+1,387
+82% +$3.43K ﹤0.01% 4298
2022
Q4
$4.53K Sell
1,683
-1,024
-38% -$2.99K ﹤0.01% 4286
2022
Q3
$9K Sell
2,707
-579
-18% -$2.62K ﹤0.01% 4125
2022
Q2
$16K Sell
3,286
-8,939
-73% -$55K ﹤0.01% 3963
2022
Q1
$93K Sell
12,225
-794,175
-98% -$6.15M ﹤0.01% 3475
2021
Q4
$7.45M Buy
806,400
+43,400
+6% +$461K ﹤0.01% 2228
2021
Q3
$10.9M Buy
+763,000
New +$11.8M ﹤0.01% 2097

Other funds holding ORGO

Fidelity Investments's ORGO Position: Q1 2026 in Review

Fidelity Investments increased its Organogenesis Holdings (ORGO) stake by 41% in Q1 2026, buying an estimated $380K and bringing the position to 375,815 shares worth $891K. The position accounts for ﹤0.01% of the portfolio, ranked #2912.

Fidelity Investments first reported a position in ORGO in Q3 2021 and has held it in 19 quarters since. The position peaked at $10.9M in Q3 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Fidelity Investments held 375,815 shares of Organogenesis Holdings worth $891K as of Q1 2026.
  • Fidelity Investments bought 109,808 Organogenesis Holdings shares in Q1 2026, an estimated $380K.
  • Organogenesis Holdings made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2912 holding.
  • Fidelity Investments first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 19 quarters since.
  • Fidelity Investments's Organogenesis Holdings position peaked at $10.9M in Q3 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.